BWXT Celebrates Deployment of USS Gerald R. Ford
America’s Newest Aircraft Carrier is Powered by BWXT-Manufactured Naval Nuclear Reactors
BWXT-led Team Awarded $45 Billion Environmental Management Contract for DOE’s Hanford Site
BWX Technologies, Inc. (NYSE: BWXT) announced a contract with an estimated value of up to $45 billion over a 10-year ordering period from the U.S. Department of Energy (DOE) for environmental management operations at the Hanford Site in Washington.
BWXT Subsidiary Awarded $428 Million Contract for Uranium Conversion and Purification Services
BWX Technologies, Inc. (NYSE: BWXT) announced that its Nuclear Fuel Services, Inc. (NFS) subsidiary has been awarded a $428 million contract from the National Nuclear Security Administration (NNSA) to provide purification and conversion services for highly enriched uranium (HEU).
BWXT Expands Scope of ASME Certification
Expansion Supports Current and Future Nuclear Reactor Design Work
BWXT Awarded Engineering Contract from GE Hitachi for BWRX-300 Small Modular Reactor
(CAMBRIDGE, Ontario – March 21, 2023) – BWX Technologies, Inc. (NYSE: BWXT) today announced an engineering contract awarded by GE Hitachi Nuclear Energy (GEH) for its BWRX-300 small modular reactor (SMR) reactor pressure vessel (RPV).
BWXT Releases 2023 Sustainability Report
BWX Technologies, Inc. (NYSE: BWXT) has released its 2023 Sustainability Report
BWX Technologies Reports Fourth-Quarter and Full-Year 2022 Results
BWX Technologies, Inc. (NYSE: BWXT) reported fourth-quarter and full-year 2022 results.
BWXT Commercial Operations Names Monifa Miller as Senior Director of Corporate Affairs
(CAMBRIDGE, ON – February 13, 2023) – BWX Technologies, Inc. (NYSE: BWXT) has appointed Monifa A. Miller as senior director of corporate affairs for BWXT’s Commercial Operations segment. In this role, she will have full responsibility for all of BWXT’s communications, public affairs, government relations and community outreach activities in Canada.
BWXT Medical and Laurentis Complete Key Tc-99m Generator Program Milestone
(Ottawa, Ontario – February 1, 2023) – Life-saving Molybdenum-99 (Mo-99) isotopes can now be produced at Ontario Power Generation’s (OPG) Darlington Nuclear Generating Station, thanks to the installation and initial commissioning of an innovative isotope system by Laurentis Energy Partners and BWXT Medical Ltd. (NYSE: BWXT).
Fusion Pharmaceuticals and BWXT Medical Announce Actinium-225 Partnership to Scale Supply for Developing Targeted Alpha Therapies
Fusion Pharmaceuticals Inc. (Nasdaq: FUSN), and BWXT Medical Ltd., a subsidiary of BWX Technologies, Inc. (NYSE: BWXT), today announced that the companies have entered into a preferred partner agreement for the supply of actinium-225.